Sebum-excretion rate and skin-surface lipid composition in Parkinson's disease before and during therapy with levodopa.
D000152:Acne Vulgaris / Q000188:drug therapy / Q000209:etiology; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005230:Fatty Acids, Nonesterified / Q000009:adverse effects; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D012629:Sebum / Q000378:metabolism*; D012867:Skin / Q000378:metabolism*; D013752:Tetracycline / Q000378:metabolism / Q000627:therapeutic use; D013997:Time Factors
D005230:Fatty Acids, Nonesterified; D008055:Lipids; D004295:Dihydroxyphenylalanine; D013752:Tetracycline